Randomized controlled trial of zoledronic acid to prevent bone loss in men receiving androgen deprivation therapy for nonmetastatic prostate cancer. [electronic resource]
Producer: 20030610Description: 2008-12 p. digitalISSN:- 0022-5347
- Aged
- Androgen Antagonists -- adverse effects
- Bone Density -- drug effects
- Diphosphonates -- therapeutic use
- Double-Blind Method
- Gonadotropin-Releasing Hormone -- adverse effects
- Humans
- Imidazoles -- therapeutic use
- Male
- Orchiectomy -- adverse effects
- Osteoporosis -- etiology
- Prostatic Neoplasms -- drug therapy
- Zoledronic Acid
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.